NRx Pharmaceuticals Inc. logo

NRx Pharmaceuticals Inc.

NRXP | NASDAQ
Chart Builder DCF Calculator
$3.29
-$0.03 (-0.90%)
At close: Sep 21, 2026, 4:00 PM ET
$3.29
$0 (0.00%)
Pre-market: Sep 22, 2026, 9:24 AM ET

Market Data

Market Cap
$56.87M
Enterprise Value
$31.02M
Beta
2.19
Average Volume
1.14M
Shares Outstanding (Diluted)
37.65M
Shares Change YoY
109.93%
Institutional Ownership
19.20%
Exchange
NASDAQ
ISIN
US6294442099

Price Performance

Price Change 1M
-7.6%
Price Change 3M
-12.5%
Price Change 6M
36.5%
Price Change YTD
25.6%
Price Change 1Y
14.6%
Price Change 3Y
28.5%
Price Change 5Y
-96.5%
1M CAGR (ann.)
-8.1%
1Y CAGR (ann.)
10.4%
5Y CAGR (ann.)
-50.4%
All-Time CAGR
-31.8%

Valuation

PE Ratio
-4.45
Forward PE
8.94
PEG Ratio
-0.04
Forward PEG
0.09
PS Ratio
16.76
Forward PS
0.60
PB Ratio
-334.53
P/FCF Ratio
-2.75
P/Adj. FCF Ratio
-2.69
P/OCF Ratio
-6.21
EV/Sales
9.14
EV/EBIT
-2.47
EV/EBITDA
-2.57
EV/FCF
-1.50
Earnings Yield
-22.5%
FCF Yield
-36.4%
Adj. FCF Yield
-37.1%

Financial Health

Net Cash
$25.85M
Total Debt
$834K
Cash & Short-Term Investments
$26.69M
Total Assets
$34.16M
Current Ratio
0.86
Quick Ratio
0.86
Debt / Equity Ratio
-7.33
Debt / EBITDA
-0.07
Debt / FCF
-0.04
OCF / Debt
-23.71
Interest Coverage
-17.45
Altman Z-Score
-13.60
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
32.7%
Operating Profit Margin
-588.2%
EBITDA Margin
-647.1%
Net Profit Margin
-691.8%
FCF Margin
-609.0%
Adj. FCF Margin
-622.0%
SBC / Revenue
12.9%
SBC Impact (per share)
-2.1%

Returns

Return on Assets
-68.7%
Return on Equity
168.7%
Return on Invested Capital
-1855.5%
Return on Capital Employed
-6980.8%
Return on Tangible Assets
-74.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
100.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
43.2%
EPS CAGR 5Y
16.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-18.4%
FCF CAGR 5Y
29.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
65.3%
Revenue Growth Next 3Y
512.0%
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
-$0.26
EPS Growth Est (next Q)
-3.7%
Revenue Est (next Q)
$1.33M
Revenue Growth Est (next Q)
448.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2
Price Target Upside
-39.2%

Cash Flow

Operating Cash Flow
$-19.77M
Free Cash Flow
$-20.67M
Adj. Free Cash Flow
$-21.11M
FCF Per Share
-$0.55
OCF Per Share
-$0.53
OCF/S Ratio
-582.6%

Income Statement

Revenue
$3.39M
Gross Profit
$1.11M
Operating Income
$-19.97M
EBITDA
$-12.08M
Net Income
$-23.48M
EPS (Diluted)
-$0.74
Revenue / Employee
$117.03K
Profit / Employee
$-809.66K
Employees
29

© 2026 bestshares.com. All rights reserved.